ASOCIATIA FARMACIILOR SI FARMACISTILOR DIN ROMANIA

EU Legislative Interests

Policies targeted: Regarding Reform of the EU pharmaceutical legislation - Development of methodologies for the implementation of pharmaceutical services, as well as the creation of national lists of pharmaceutical services at the level of EU Member States, with the goal of disease prevention and patient benefit. Link: https://eur-lex.europa.eu/legal-content/RO/TXT/?uri=CELEX:32012R0520 Link: https://health.ec.europa.eu/medicinal-products/legal-framework-governing-medicinal-products-human-use-eu/reform-eu-pharmaceutical-legislation_en Frequently Asked Questions: Revision of the Pharmaceutical legislation: https://ec.europa.eu/commission/presscorner/detail/en/qanda_23_1844 The actual situation: In Romania, the Minister of Health Order no. 2.382 of 4 November 2021 was adopted, approving the Methodology for the implementation of pharmaceutical services and the List of pharmaceutical services. This order stipulates that the implementation of pharmaceutical services must be based on good pharmaceutical practice guidelines for the provision of such services. However, these guidelines have not yet been developed. Pharmaceutical services include vaccination, testing, and counselling offered in pharmacies — services which, if implemented, could alleviate the burden on hospitals by preventing certain conditions through the involvement of pharmacists. This would also reduce the public costs associated with patient hospitalizations. Pharmaceutical activities play a vital role in disease prevention through vaccination and testing and are accessible to patients both in rural and urban areas. At the level of the European Union, the communication on the Reform of the EU pharmaceutical legislation was published (link), and we believe that all European countries should benefit from regulated pharmaceutical services, in the interest of the patient and with a focus on prevention. In conclusion, our target is to promote the development of methodologies for the implementation of pharmaceutical services, as well as the creation of national lists of pharmaceutical services at the level of EU Member States, with the goal of disease prevention and patient benefit.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

- FIP (International Pharmaceutical Federation) - https://www.fip.org/ - CPC (Confederatia Patronala Concordia) - https://concordia.ro/

Organisation Members

Nr Denumire Societate Cod Fiscal 1 FARMAGRO SRL 7429442 2 FARMACIA FARMEX 5285383 3 FARMACIA MIRUNA SRL 23645375 4 MDM FARM 19215949 5 FARM ZOO STAR SRL 4227716 6 TEXAVIT SRL 18813251 7 TEOFARM SRL 1771186 8 PRO-SANA 1344207 9 FARMACIA SOMESAN SRL 9015528 10 FARMACIA GEORGE SRL 25602923 11 FARMACIA FLORINA SRL 1499163 12 COMAY 809738 13 SICOFARM SRL 16368395 14 GENTIANA SRL 2201108 15 PHARMAPLUS SRL 14924168 16 ZEN PHARMA SRL 27059328 17 LARA FARM SRL 17974659 18 FARMACIA ANA-MARIA SRL 4479 19 CONVALARIA SRL 7015688 20 FARMACIA ARDEALUL SRL 3426630 21 AXA FARM SRL 12908832 22 SALOFARM SRL 952877 23 FARMACIA BAJAN SRL 6670441 24 PROFESSIONAL FARMA LINE SRL 13637588 25 HELP FLUX SRL 8043104 26 MEDIMFARM TOPFARM 35315710 27 NAPOFARM SRL 31303438 28 CERULEX SRL 26915759 29 NORDPHARM SRL 6077518 30 REMEDIUM FARM SRL 2891679 31 MYOSOTIS 1633019 32 MINI-FARM SRL 8868896 33 DUCFARM SRL 13607501 34 FARMACIA ADRIANA 18962881 35 LIFE FARM SRL 22524588

Additional Information

Context and Background for the Financial Information Provided: AFFR is a non-profit association that represents the interests of pharmacies and pharmacists in Romania. The financial information provided reflects the total revenues and expenses for the most recent financial year. The association is primarily funded through membership fees paid by its 35 member companies (pharmacies), along donations for the association purpose. AFFR does not receive EU funding through subsidiary companies, nor does it rely on external funding from third parties for its operational activities. All financial resources are directed towards representing the professional and representing pharmaceutical companies. Additionally, the association's representatives, including board members, are unpaid. The activities related to advocacy, policy development, and representation are conducted without the need for significant external financial support. The relatively modest budget is reflective of the association's operational scale. No substantial costs are incurred by the association beyond the day-to-day running of its office and its advocacy work.